Coronavirus-Liveticker: +++ 21:48 Frankreich meldet mehr als 10 000 Neuinfektionen +++ n-tv.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from n-tv.de Daily Mail and Mail on Sunday newspapers.
Coronavirus-Liveticker: +++ 02:20 Lage in Spanien spitzt sich zu +++ n-tv.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from n-tv.de Daily Mail and Mail on Sunday newspapers.
URL copied
Zydus Cadila seeks DCGI nod for use of hepatitis drug for COVID-19 treatment
Drug firm Zydus Cadila on Monday said it has sought approval from the domestic drug regulator Drugs Controller General of India (DCGI) for the additional indication of its hepatitis drug Pegylated Interferon Alpha-2b for treating COVID-19. Phase-III clinical trials with Pegylated Interferon Alpha 2b, which the company sells under the brand name PegiHep has shown promising results in treating COVID-19, Zydus Cadila said in a statement.
The interim results indicate that the drug when administered early on, could help patients recover faster and avoid much of the complications seen in the advanced stages of the disease, it added.
New Delhi (India) [India], April 5 (ANI): Pharmaceutical Company Zydus Cadila on Monday informed that it has sought approval of the Drugs Controller General of India (DGCI) for using its hepatitis drug for the treatment of coronavirus.